# Is Total Arterial Revascularization Superior to Multiarterial Grafting in Coronary Artery Bypass Grafting

> **NCT06766084** · — · COMPLETED · sponsor: **Technion, Israel Institute of Technology** · enrollment: 7878 (actual)

## Conditions studied

- CABG
- Revascularization

## Interventions

- **PROCEDURE:** CABG

## Key facts

- **NCT ID:** NCT06766084
- **Lead sponsor:** Technion, Israel Institute of Technology
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2009-01-01
- **Primary completion:** 2023-12-31
- **Final completion:** 2023-12-31
- **Target enrollment:** 7878 (ACTUAL)
- **Last updated:** 2025-01-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06766084

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06766084, "Is Total Arterial Revascularization Superior to Multiarterial Grafting in Coronary Artery Bypass Grafting". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT06766084. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*